Swiss National Bank reduced its position in Molina Healthcare, Inc (NYSE:MOH - Free Report) by 2.6% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 161,300 shares of the company's stock after selling 4,300 shares during the quarter. Swiss National Bank owned 0.30% of Molina Healthcare worth $53,131,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Amalgamated Bank boosted its holdings in shares of Molina Healthcare by 0.3% in the 1st quarter. Amalgamated Bank now owns 11,580 shares of the company's stock worth $3,814,000 after purchasing an additional 33 shares in the last quarter. Deseret Mutual Benefit Administrators boosted its holdings in shares of Molina Healthcare by 60.7% in the 1st quarter. Deseret Mutual Benefit Administrators now owns 90 shares of the company's stock worth $30,000 after purchasing an additional 34 shares in the last quarter. JLB & Associates Inc. boosted its holdings in shares of Molina Healthcare by 0.3% in the 1st quarter. JLB & Associates Inc. now owns 10,626 shares of the company's stock worth $3,500,000 after purchasing an additional 36 shares in the last quarter. Coldstream Capital Management Inc. boosted its holdings in shares of Molina Healthcare by 2.1% in the 4th quarter. Coldstream Capital Management Inc. now owns 2,346 shares of the company's stock worth $683,000 after purchasing an additional 48 shares in the last quarter. Finally, Rothschild Investment LLC boosted its holdings in shares of Molina Healthcare by 126.3% in the 1st quarter. Rothschild Investment LLC now owns 86 shares of the company's stock worth $28,000 after purchasing an additional 48 shares in the last quarter. 98.50% of the stock is currently owned by hedge funds and other institutional investors.
Insider Buying and Selling
In other Molina Healthcare news, Director Ronna Romney sold 700 shares of the company's stock in a transaction that occurred on Wednesday, August 6th. The stock was sold at an average price of $153.74, for a total transaction of $107,618.00. Following the completion of the transaction, the director owned 17,131 shares of the company's stock, valued at $2,633,719.94. This represents a 3.93% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, COO James Woys purchased 10,000 shares of the stock in a transaction on Monday, August 4th. The shares were acquired at an average cost of $155.94 per share, with a total value of $1,559,400.00. Following the transaction, the chief operating officer directly owned 74,331 shares in the company, valued at $11,591,176.14. The trade was a 15.54% increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 1.10% of the company's stock.
Molina Healthcare Trading Up 3.8%
MOH traded up $6.13 during midday trading on Friday, reaching $165.76. 499,749 shares of the company's stock traded hands, compared to its average volume of 965,308. The firm has a fifty day moving average of $225.87 and a two-hundred day moving average of $282.91. The stock has a market capitalization of $8.98 billion, a price-to-earnings ratio of 8.17 and a beta of 0.52. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.66 and a quick ratio of 1.66. Molina Healthcare, Inc has a 52 week low of $151.95 and a 52 week high of $365.23.
Molina Healthcare (NYSE:MOH - Get Free Report) last released its quarterly earnings results on Wednesday, July 23rd. The company reported $5.48 EPS for the quarter, missing analysts' consensus estimates of $5.50 by ($0.02). The business had revenue of $11.43 billion for the quarter, compared to the consensus estimate of $10.94 billion. Molina Healthcare had a net margin of 2.60% and a return on equity of 27.72%. The company's revenue for the quarter was up 15.7% on a year-over-year basis. During the same period in the previous year, the company earned $5.86 EPS. On average, equities analysts anticipate that Molina Healthcare, Inc will post 24.4 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
A number of research firms have recently issued reports on MOH. UBS Group cut their price objective on Molina Healthcare from $260.00 to $180.00 and set a "neutral" rating for the company in a report on Friday, July 25th. Wall Street Zen cut Molina Healthcare from a "buy" rating to a "hold" rating in a report on Sunday, June 29th. Truist Financial reissued a "hold" rating and issued a $180.00 target price (down previously from $335.00) on shares of Molina Healthcare in a research note on Friday, July 25th. Barclays lowered their target price on Molina Healthcare from $270.00 to $186.00 and set an "equal weight" rating for the company in a research note on Friday, July 25th. Finally, Mizuho lowered their target price on Molina Healthcare from $400.00 to $330.00 and set an "outperform" rating for the company in a research note on Friday, July 11th. Eleven equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to data from MarketBeat, Molina Healthcare has a consensus rating of "Hold" and an average price target of $242.91.
Get Our Latest Research Report on Molina Healthcare
About Molina Healthcare
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Featured Stories

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.